Brief: Anixa Biosciences Gets FDA Clearance For Ovarian Cancer Trial

Anixa Biosciences

30/08/2021 13:34

Aug 30 (Reuters) - Anixa Biosciences Inc  ANIX.O :
    * ANIXA BIOSCIENCES AND MOFFITT CANCER CENTER ANNOUNCE FDA
CLEARANCE TO INITIATE CLINICAL TRIAL OF OVARIAN CANCER CAR-T
IMMUNOTHERAPY
    * ANIXA BIOSCIENCES AND MOFFITT CANCER CENTER ANNOUNCE FDA
CLEARANCE TO INITIATE CLINICAL TRIAL OF OVARIAN CANCER CAR-T
IMMUNOTHERAPY
    * ANIXA BIOSCIENCES INC - ROBERT WENHAM, CHAIR OF
GYNECOLOGICAL
ONCOLOGY AT MOFFITT WILL LEAD CLINICAL TRIAL

Source text for Eikon:  ID:nPnbrTBL1a 
Further company coverage:  ANIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))